106 related articles for article (PubMed ID: 38728194)
1. Role of MEK1 and DIAPH3 expression in colorectal adenoma-carcinoma sequence.
Foda AAM; El-Hawary AK; Elnaghi K; Eldehna WM; Enan ET
Tumour Biol; 2024; 46(1):1-11. PubMed ID: 38728194
[TBL] [Abstract][Full Text] [Related]
2. Identification of an intermediate signature that marks the initial phases of the colorectal adenoma-carcinoma transition.
Tang H; Guo Q; Zhang C; Zhu J; Yang H; Zou YL; Yan Y; Hong D; Sou T; Yan XM
Int J Mol Med; 2010 Nov; 26(5):631-41. PubMed ID: 20878084
[TBL] [Abstract][Full Text] [Related]
3. ELR+ CXC chemokine expression in benign and malignant colorectal conditions.
Rubie C; Frick VO; Wagner M; Schuld J; Gräber S; Brittner B; Bohle RM; Schilling MK
BMC Cancer; 2008 Jun; 8():178. PubMed ID: 18578857
[TBL] [Abstract][Full Text] [Related]
4. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
5. Expression of TSP50, SERCA2 and IL-8 in Colorectal Adenoma and Carcinoma: Correlation to Clinicopathological Factors.
Youssef HMK; Radi DA; Abd El-Azeem MA
Pathol Oncol Res; 2021; 27():1609990. PubMed ID: 34744521
[No Abstract] [Full Text] [Related]
6. Reduced expression of microenvironmental Th1 cytokines accompanies adenomas-carcinomas sequence of colorectum.
Cui G; Goll R; Olsen T; Steigen SE; Husebekk A; Vonen B; Florholmen J
Cancer Immunol Immunother; 2007 Jul; 56(7):985-95. PubMed ID: 17160410
[TBL] [Abstract][Full Text] [Related]
7. Expression of miR-22 profiling in colorectal normal-adenoma-carcinoma sequence.
Li G; Zhao D; Peng X; Zhao Y
Gene; 2024 Feb; 894():147955. PubMed ID: 37925119
[TBL] [Abstract][Full Text] [Related]
8. Identification of hub genes in colorectal cancer based on weighted gene co-expression network analysis and clinical data from The Cancer Genome Atlas.
Zhang Y; Luo J; Liu Z; Liu X; Ma Y; Zhang B; Chen Y; Li X; Feng Z; Yang N; Feng D; Wang L; Song X
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34308980
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of PCNA and CD34 in colorectal adenomas and carcinomas using specified automated cellular image analysis system: a clinicopathologic study.
Qasim BJ; Ali HH; Hussein AG
Saudi J Gastroenterol; 2012; 18(4):268-76. PubMed ID: 22824771
[TBL] [Abstract][Full Text] [Related]
10. IL-17A in the tumor microenvironment of the human colorectal adenoma-carcinoma sequence.
Cui G; Yuan A; Goll R; Florholmen J
Scand J Gastroenterol; 2012 Nov; 47(11):1304-12. PubMed ID: 22989213
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition.
Kalmár A; Nagy ZB; Galamb O; Csabai I; Bodor A; Wichmann B; Valcz G; Barták BK; Tulassay Z; Igaz P; Molnár B
BMC Cancer; 2019 Nov; 19(1):1059. PubMed ID: 31694571
[TBL] [Abstract][Full Text] [Related]
12. [Wif-1 methylation and β-catenin expression in colorectal serrated lesions].
Fang Y; Wang L; Zhang Y; Ge C; Xu C
Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):15-9. PubMed ID: 24713243
[TBL] [Abstract][Full Text] [Related]
13. Enhanced shedding of extracellular vesicles from amoeboid prostate cancer cells: potential effects on the tumor microenvironment.
Kim J; Morley S; Le M; Bedoret D; Umetsu DT; Di Vizio D; Freeman MR
Cancer Biol Ther; 2014 Apr; 15(4):409-18. PubMed ID: 24423651
[TBL] [Abstract][Full Text] [Related]
14. DIAPH3 is a prognostic biomarker and inhibit colorectal cancer progression through maintaining EGFR degradation.
Huang R; Wu C; Wen J; Yu J; Zhu H; Yu J; Zou Z
Cancer Med; 2022 Dec; 11(23):4688-4702. PubMed ID: 35538918
[TBL] [Abstract][Full Text] [Related]
15. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
16. Diaphanous-related formin-3 overexpression inhibits the migration and invasion of triple-negative breast cancer by inhibiting RhoA-GTP expression.
Jiang J
Biomed Pharmacother; 2017 Oct; 94():439-445. PubMed ID: 28779705
[TBL] [Abstract][Full Text] [Related]
17. DIAPH3 governs the cellular transition to the amoeboid tumour phenotype.
Hager MH; Morley S; Bielenberg DR; Gao S; Morello M; Holcomb IN; Liu W; Mouneimne G; Demichelis F; Kim J; Solomon KR; Adam RM; Isaacs WB; Higgs HN; Vessella RL; Di Vizio D; Freeman MR
EMBO Mol Med; 2012 Aug; 4(8):743-60. PubMed ID: 22593025
[TBL] [Abstract][Full Text] [Related]
18. Identification of disrupted pathways in ulcerative colitis-related colorectal carcinoma by systematic tracking the dysregulated modules.
Wu D; Li Q; Song G; Lu J
J BUON; 2016; 21(2):366-74. PubMed ID: 27273946
[TBL] [Abstract][Full Text] [Related]
19. Altered miR-21, miRNA-148a Expression in Relation to KRAS Mutation Status as Indicator of Adenoma-Carcinoma Transitional Pattern in Colorectal Adenoma and Carcinoma Lesions.
Igder S; Mohammadiasl J; Mokarram P
Biochem Genet; 2019 Dec; 57(6):767-780. PubMed ID: 30997628
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive look at transcription factor gene expression changes in colorectal adenomas.
Vonlanthen J; Okoniewski MJ; Menigatti M; Cattaneo E; Pellegrini-Ochsner D; Haider R; Jiricny J; Staiano T; Buffoli F; Marra G
BMC Cancer; 2014 Jan; 14():46. PubMed ID: 24472434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]